UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

More on: venous thromboembolism and mortality after hip fracture: the ESCORTE study

Journal of thrombosis and haemostasis, 2006-07, Vol.4 (7), p.1642-1645

2006

Volltextzugriff (PDF)

P429 PROGNOSTIC IMPACT OF ROUTINE SIX–MONTH EXERCISE STRESS TEST AFTER COMPLEX LEFT MAIN BIFURCATION PCI

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

P80 PROGNOSTIC IMPACT OF NEW ONSET ATRIAL FIBRILLATION AFTER SINGLE OR DOUBLE STENT LEFT MAIN BIFURCATION PCI

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

P66 GENDER–RELATED DIFFERENCES IN CLINICAL OUTCOMES AFTER EITHER SINGLE OR DOUBLE LEFT MAIN BIFURCATION STENTING

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

P164 VERY LONG TERM FOLLOW UP OF PRIMARY TRANSCATHETER PATENT FORAMEN OVALE CLOSURE FOR MIGRAINE CURE

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1181-1187

2001

Volltextzugriff (PDF)

A Placebo-controlled, Double-blind Study of Mesoglycan in the Treatment of Chronic Venous Ulcers

European journal of vascular and endovascular surgery, 2001-10, Vol.22 (4), p.365-372

2001

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Thrombosis and haemostasis, 1992-02, Vol.67 (2), p.203-208

1992

Volltextzugriff (PDF)

Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure

Nephrology, dialysis, transplantation, 1997-11, Vol.12 (11), p.2349-2354

1997

Volltextzugriff (PDF)

Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis

British journal of surgery, 1992-06, Vol.79 (6), p.505-509

1992

Volltextzugriff (PDF)

Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice

Thrombosis and haemostasis, 1994-04, Vol.71 (4), p.468-473

1994

Volltextzugriff (PDF)

Pharmacodynamics and Pharmacokinetics of Dermatan Sulfate in Humans

Blood, 1989-10, Vol.74 (5), p.1577-1582

1989

Volltextzugriff (PDF)

Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy

Thrombosis and haemostasis, 1994-05, Vol.71 (5), p.553-557

1994

Volltextzugriff (PDF)

Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer

Thrombosis and haemostasis, 1999, Vol.82 (7), p.30-34

1999

Volltextzugriff (PDF)

Dermatan sulfate as a potential antithrombotic drug

Haematologica (Roma), 1987-09, Vol.72 (5), p.459

1987

Volltextzugriff (PDF)

The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and βTG/PF4 release

Thrombosis research, 1990-02, Vol.57 (3), p.405-414

1990

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans

Blood, 1989-10, Vol.74 (5), p.1577-1582

1989

Volltextzugriff (PDF)

The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers

British journal of clinical pharmacology, 1991-09, Vol.32 (3), p.361-366

1991

Volltextzugriff (PDF)

A survey of the clinical experience with dermatan sulfate

Seminars in thrombosis and hemostasis, 1991, Vol.17, p.199-204

1991

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure

British journal of clinical pharmacology, 1993-03, Vol.35 (3), p.335-339

1993

Volltextzugriff (PDF)

Human pharmacokinetics and pharmacodynamics of MF 701 dermatan sulfate administered by continuous intravenous infusion

Thrombosis and haemostasis, 1990, Vol.64 (2), p.256-259

1990

Volltextzugriff (PDF)

Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers

Thrombosis research, 1991-06, Vol.62 (6), p.663-672

1991

Volltextzugriff (PDF)

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

British journal of haematology, 1999-01, Vol.104 (1), p.87-89

1999

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of intramuscular dermatan sulfate revisited : a single- and repeated-dose study in healthy volunteers

Clinical drug investigation, 2003-01, Vol.23 (8), p.533-543

2003

Volltextzugriff (PDF)

Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group

Thrombosis and haemostasis, 1999-07, Vol.82 (1), p.30

1999

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Englisch
(44)
Italienisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

More on: venous thromboembolism and mortality after hip fracture: the ESCORTE study

P429 PROGNOSTIC IMPACT OF ROUTINE SIX–MONTH EXERCISE STRESS TEST AFTER COMPLEX LEFT MAIN BIFURCATION PCI

P80 PROGNOSTIC IMPACT OF NEW ONSET ATRIAL FIBRILLATION AFTER SINGLE OR DOUBLE STENT LEFT MAIN BIFURCATION PCI

P66 GENDER–RELATED DIFFERENCES IN CLINICAL OUTCOMES AFTER EITHER SINGLE OR DOUBLE LEFT MAIN BIFURCATION STENTING

P164 VERY LONG TERM FOLLOW UP OF PRIMARY TRANSCATHETER PATENT FORAMEN OVALE CLOSURE FOR MIGRAINE CURE

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

A Placebo-controlled, Double-blind Study of Mesoglycan in the Treatment of Chronic Venous Ulcers

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure

Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis

Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice

Pharmacodynamics and Pharmacokinetics of Dermatan Sulfate in Humans

Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy

Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer

Dermatan sulfate as a potential antithrombotic drug

The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and βTG/PF4 release

Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans

The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers

A survey of the clinical experience with dermatan sulfate

The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure

Human pharmacokinetics and pharmacodynamics of MF 701 dermatan sulfate administered by continuous intravenous infusion

Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

Pharmacokinetics and pharmacodynamics of intramuscular dermatan sulfate revisited : a single- and repeated-dose study in healthy volunteers

Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group

Suchergebnisse filtern